title: Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Rey
authors.forename: Aude
authors.initials: A
authors.lastname: Charbonnier
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Schiano de Colella
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Stoppa
authors.forename: Isabelle
authors.initials: I
authors.lastname: Poizot-Martin
authors.forename: Jean-Albert
authors.initials: JA
authors.lastname: Gastaut
authors.forename: Régis T
authors.initials: RT
authors.lastname: Costello
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone